525 related articles for article (PubMed ID: 18559517)
21. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.
Achyut BR; Bader DA; Robles AI; Wangsa D; Harris CC; Ried T; Yang L
PLoS Genet; 2013; 9(2):e1003251. PubMed ID: 23408900
[TBL] [Abstract][Full Text] [Related]
22. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
23. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.
Mishra S; Deng JJ; Gowda PS; Rao MK; Lin CL; Chen CL; Huang T; Sun LZ
Oncogene; 2014 Jul; 33(31):4097-106. PubMed ID: 24037531
[TBL] [Abstract][Full Text] [Related]
26. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
27. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
[TBL] [Abstract][Full Text] [Related]
28. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW
Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665
[TBL] [Abstract][Full Text] [Related]
29. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
30. Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells.
Tanner MJ; Welliver RC; Chen M; Shtutman M; Godoy A; Smith G; Mian BM; Buttyan R
PLoS One; 2011 Jan; 6(1):e16027. PubMed ID: 21267466
[TBL] [Abstract][Full Text] [Related]
31. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth.
Placencio VR; Li X; Sherrill TP; Fritz G; Bhowmick NA
PLoS One; 2010 Sep; 5(9):e12920. PubMed ID: 20886110
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
[TBL] [Abstract][Full Text] [Related]
35. Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.
Teixeira AL; Gomes M; Nogueira A; Azevedo AS; Assis J; Dias F; Santos JI; Lobo F; Morais A; Maurício J; Medeiros R
PLoS One; 2013; 8(8):e72419. PubMed ID: 23951322
[TBL] [Abstract][Full Text] [Related]
36. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.
Kundu SD; Kim IY; Yang T; Doglio L; Lang S; Zhang X; Buttyan R; Kim SJ; Chang J; Cai X; Wang Z; Lee C
Prostate; 2000 May; 43(2):118-24. PubMed ID: 10754527
[TBL] [Abstract][Full Text] [Related]
37. Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.
Franco OE; Jiang M; Strand DW; Peacock J; Fernandez S; Jackson RS; Revelo MP; Bhowmick NA; Hayward SW
Cancer Res; 2011 Feb; 71(4):1272-81. PubMed ID: 21303979
[TBL] [Abstract][Full Text] [Related]
38. FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stroma.
Carstens JL; Shahi P; Van Tsang S; Smith B; Creighton CJ; Zhang Y; Seamans A; Seethammagari M; Vedula I; Levitt JM; Ittmann MM; Rowley DR; Spencer DM
Cancer Res; 2014 Jan; 74(2):609-20. PubMed ID: 24305876
[TBL] [Abstract][Full Text] [Related]
39. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
Cheng N; Bhowmick NA; Chytil A; Gorksa AE; Brown KA; Muraoka R; Arteaga CL; Neilson EG; Hayward SW; Moses HL
Oncogene; 2005 Jul; 24(32):5053-68. PubMed ID: 15856015
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]